‘Game-changing:’ Milwaukee surgeon first in area to use FDA-approved drug to shine light on hidden lung cancer
A new drug is helping surgeons see cancer that once went undetected, lighting up tumors in real time during surgery.
A new drug is helping surgeons see cancer that once went undetected, lighting up tumors in real time during surgery.
When a tough case of double pneumonia turned into a surprise ovarian cancer diagnosis, Peggy became the first patient in Northeast Wisconsin and Michigan’s Upper Peninsula to benefit from a breakthrough in medical technology.
A new invention is shining a light on cancer and helping surgeons find microscopic lesions. The special light allows surgeons like New Jersey’s Dr. Matthew Puc to find cancer they wouldn’t normally be able to see. It’s allowing them to …
It’s a breakthrough that’s helping the outcomes of lung cancer. The “glow in the dark” technology illuminates cancer cells, helping doctors remove lesions the naked eye might miss.
More than 225,000 Americans will be diagnosed with lung cancer this year, according to the Lung Cancer Research Foundation. A revolutionary cancer detection tool called Cytalux is now helping surgeons remove cancerous cells with greater precision.
UVA Health is now the first health system in Virginia to use Cytalux, a prescription medication that helps surgeons better detect lung cancer during surgery.
Advances in medicine are improving the outcomes of lung cancer surgeries in Central Florida.
For more information and risk-related details, visit https://cytaluxhcp.com/important-safety-information/